A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis
Clicks: 173
ID: 111103
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.0
/100
173 views
26 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #304 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This study demonstrated that topical imiquimod (TLR7 agonist) before intradermal hepatitis B vaccination was safe, with significantly better seroprotection than
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (20 words).
Try re-searching for a better abstract.
| Reference Key |
fan-ngaiclinicala
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hung, Ivan Fan-Ngai;Yap, Desmond Yat-Hin;Yip, Terence Pok-Siu;Zhang, Ricky Ruiqi;To, Kelvin Kai-Wang;Chan, Kwok-Hung;Tang, Sydney Chi-Wai;Lui, Sing-Leung;Levin, Yotam;Kochba, Efrat;Lau, Johnson Yiu-Nam;Yuen, Man-Fung;Chan, Tak-Mao;Yuen, Kwok-Yung; |
| Journal | clinical infectious diseases |
| Year | Year not found |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.